COMMUNIQUÉS West-GlobeNewswire

Interim results for the six months ended June 30, 2024

26/09/2024 - 14:30

September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage [...]

Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)

26/09/2024 - 14:30

MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- From September 28 to October 1, the Shriners Hospitals for Children - Canada will host the 4 th International Symposium on Arthrogryposis . Organized in collaboration with [...]

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

25/09/2024 - 22:30

PHILADELPHIA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

25/09/2024 - 22:05

CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]

MDxHealth Announces Launch of Offering of Ordinary Shares

25/09/2024 - 22:05

MDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (“ mdxhealth ” or the “ Company ”), a commercial-stage [...]

BioVie Inc. Announces Closing of Public Offering

25/09/2024 - 22:05

CARSON CITY, Nev., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

25/09/2024 - 22:05

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA stabilization from urine // QIAGEN to commercialize set with the [...]

Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024

25/09/2024 - 22:05

AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of data [...]

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

25/09/2024 - 22:05

Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global [...]

ImPact Biotech to Present at Oppenheimer Private Life Sciences Company Showcase

25/09/2024 - 22:01

TEL AVIV, Israel, Sept. 25, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid [...]

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

25/09/2024 - 22:01

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model Abivax [...]

Inventiva provides a corporate update and reports its unaudited 2024 first-half financial results

25/09/2024 - 22:00

Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical powering of the study expected to be superior to 95% for both doses [...]

Inventiva fait un point sur ses activités et publie ses résultats financiers non audités du premier semestre 2024

25/09/2024 - 22:00

Le recrutement dans l'étude clinique NATiV3 progresse, avec plus de 85 % du nombre cible de patients randomisés dans la cohorte principale et d'une puissance statistique de l'étude qui devrait être supérieure à 95 % [...]

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

25/09/2024 - 22:00

NEWTON, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic [...]

HOOPP President & CEO Jeff Wendling announces retirement

25/09/2024 - 21:00

TORONTO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Jeff Wendling, President & CEO of the Healthcare of Ontario Pension Plan (HOOPP), announced today that he will be retiring in 2025 after more than a quarter of a century [...]

Nextech Launches Expanded Payments Functionality

25/09/2024 - 20:30

New Features to Enhance Patient Experience and Increase Speed to Revenue TAMPA, Fla., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of comprehensive technology solutions for specialty physician practices, [...]

Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting

25/09/2024 - 18:00

Findings reinforce the value of the MMRF’s integrated clinical and translational research expertise to provide a deeper understanding of multiple myeloma and improve how the disease is treated The MMRF CoMMpass SM Study [...]

SLEEVER® and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal: SEELCAP® ONEGO

25/09/2024 - 18:00

The SEELCAP® ONEGO innovation is the fruit of a long-term partnership between SLEEVER® and CARBIOS that combines their expertise to produce more environmentally friendly packaging security SEELCAP® ONEGO will be [...]

SLEEVER® et CARBIOS lancent le premier concept de témoin d’effraction Home Compost biodégradable sur le marché mondial : SEELCAP® ONEGO

25/09/2024 - 18:00

L’innovation SEELCAP® ONEGO est le fruit du partenariat long terme entre SLEEVER® et CARBIOS qui conjuguent leurs expertises pour la sécurisation d’emballages plus respectueux de l’environnement SEELCAP® ONEGO sera [...]